ENTX

ENTX

USD

Entera Bio Ltd. Ordinary Shares

$2.040-0.002 (-0.098%)

Reaalajas hind

Healthcare
Biotehnoloogia
Iisrael

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$2.042

Kõrge

$2.090

Madal

$2.000

Maht

0.02M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

92.7M

Tööstusharu

Biotehnoloogia

Riik

Israel

Kauplemisstatistika

Keskmine maht

0.04M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $1.41Praegune $2.040Kõrge $2.79

Seotud uudised

GlobeNewswire

OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress

MIAMI and JERUSALEM, July 08, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) ("OPKO") and Entera Bio Ltd. (NASDAQ:ENTX) ("Entera") today announced that their abstract "First-in-Class Oral GLP-2 Analog for

Vaata rohkem
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress
GlobeNewswire

Entera Bio Data for EB613 Effects on Trabecular and Cortical Bone in Post-Menopausal Women with Osteoporosis Selected for Oral Presentation at ASBMR 2025 Annual Meeting

JERUSALEM, June 26, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ:ENTX), a leader in the development of oral peptides and proteins replacement therapies, announced that new data exploring the dual actions of EB613

Vaata rohkem
Entera Bio Data for EB613 Effects on Trabecular and Cortical Bone in Post-Menopausal Women with Osteoporosis Selected for Oral Presentation at ASBMR 2025 Annual Meeting